Answer:
Lactated Ringer's solution
Explanation:
After a burn injury, the patient usualy goes into hypovolemia (rapid loss in blood or bodily fluids because of severe bleeding from injury) this results in hypoperfusion (low blood flow), therefore fluid resuscitation is required in order to replace the lost fluids.
Ringers lactate is generally used because it helps to replace fluids and electrolytes in order increase the blood pressure, it is also used because the by-products of lactate metabolism in the liver counteract the acidosis, which is a chemical imbalance that occurs with acute loss of fluid or kidney failure
Answer:
The consequences of a shrinking workforce population include:
Political:
Decision-making domination by the older adults
Government by the aged (gerontocracy), who may be more concerned with their today than with the future.
More conservative political thoughts and practices
Social:
Lack of adequate welfare system
Negative impact on education and innovation
Decline in socio-cultural activities
Stressed family life
Reduced labor market
Pressure on the healthcare facilities and social insurance
Economic:
Reduced workforce
Decline in labor productivity
Higher labor costs
Contraction of businesses
Lack of international competitiveness
Deteriorating fiscal balance
Explanation:
A shrinking workforce population is filled by more aged adults than children and youth. This situation increases the dependency ratio. It constrains the healthcare system and increases the need for governments to pay out more in benefits to the less-productive class without commensurate support from the workforce population.
Answer:
I don't know the actual answer, but I do know that any other provider or covered entity are exceptions. You can take a look at "https://www.healthcarecompliancepros.com/blog/exceptions-to-the-privacy-rule" and it will give some more information on the exceptions?
Explanation:
The main objective of phase 3 trials is to verify the therapeutic action of a new substance in a large number of patients, essentially to determine the risk/benefit ratio. Before phase 3, the substance is not regarded as a drug, but after a positive phase 3 trial it becomes a drug.
